Literature DB >> 6359176

Pentoxifylline enhances formation of prostacyclin from rat vascular and renal tissue.

H Sinzinger.   

Abstract

In 6 months old male Wistar rats 15 mg pentoxifylline/kg body weight were given intravenously in a single dose. The animals were sacrificed after 30, 60, 120 and 240 minutes respectively. It was confirmed that a single pentoxifylline administration enhanced prostacyclin generation by vascular and renal tissue samples, reaching its maximum 60 minutes after the treatment. The time course for PGI2-generation behaves differently in the tissues examined. It is concluded that the drug pentoxifylline might exert its beneficial role in the treatment of peripheral vascular disease at least in part by its influence on hemostatic balance at the endothelial-platelet interaction level.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6359176     DOI: 10.1016/0262-1746(83)90085-9

Source DB:  PubMed          Journal:  Prostaglandins Leukot Med        ISSN: 0262-1746


  4 in total

1.  Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock.

Authors:  T Staudinger; E Presterl; W Graninger; G J Locker; S Knapp; K Laczika; G Klappacher; B Stoiser; A Wagner; P Tesinsky; H Kordova; M Frass
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

2.  The effects of pentoxifylline on renal function and free radical production in unilateral ureteral obstruction.

Authors:  Adnan Aslan; Güngör Karagüzel; Firat Güngör; Nimet Izgüt-Uysal; Funda Aydin; Mustafa Melikoğlu
Journal:  Urol Res       Date:  2003-07-25

Review 3.  Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.

Authors:  A Ward; S P Clissold
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

Review 4.  Inflammatory Targets in Diabetic Nephropathy.

Authors:  Javier Donate-Correa; Desirée Luis-Rodríguez; Ernesto Martín-Núñez; Víctor G Tagua; Carolina Hernández-Carballo; Carla Ferri; Ana Elena Rodríguez-Rodríguez; Carmen Mora-Fernández; Juan F Navarro-González
Journal:  J Clin Med       Date:  2020-02-07       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.